Video Series

Key opinion leaders discuss ongoing clinical trials for respiratory syncytial virus vaccines.

The panel discusses potential therapy options for adults infected with respiratory syncytial virus.

In their final thoughts, medical experts highlight key considerations in the atopic dermatitis (AD) treatment landscape.

Amy Brennan underlines the impact of affordability and how it may be inhibiting the patient atopic dermatitis (AD) treatment process.

Key opinion leaders provide insight on the effect of racial disparities on patients with cervical and breast cancer.

Experts expand on racial and social factors influencing maternal mortality.

Payor considerations in the treatment of HIV are explored.

A panel of experts open a discussion surrounding the current disease landscape of HIV.

In their closing thoughts, the panelists discuss financial considerations for treating patients with RRMM.

Barriers to sufficient multiple myeloma treatment are explored.

Financial impacts associated with respiratory syncytial virus infection are highlighted.

Dr Welch leads a conversation regarding strategies to increase awareness of respiratory syncytial virus.

Wanda Filer, MD, MBA, FAAFP, discusses the prevalence of RSV.

Expert panelists discuss bridging communication between payers and providers in the AD treatment pathway.

White-glove service provided by local pharmacies can increase convenience for patients navigating atopic dermatitis (AD) treatment options.

Sharon Deans, MD, MPH, MBA, and Roxie Cannon Wells, MD, discuss disparities affecting maternal mortality rates.

Ensuring appropriate pre-pregnancy through postnatal care is critical for optimal health of mother and child.

Cytokine release syndrome can limit aggressive RRMM treatment strategies.

Panelists discuss relapsed/refractory multiple myeloma treatment regimen strategies.

The panel measures the significance of an RSV vaccine in relation to other vaccines in circulation.

Traditionally thought of as a pediatric disease, RSV also affects older patient populations.

Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.

Off-label use of JAK inhibitors can prove beneficial in the treatment of several dermatologic conditions.

Soyini Hawkins, MD, MPH, FACOG, drives a conversation regarding the impact of race in diagnosing endometriosis.

Early detection of uterine fibroids and endometriosis has been powered by the Affordable Care Act, ultimately improving prognosis for patient outcomes.

Key opinion leaders dive into the use of bispecific treatment options for RRMM.

Various treatment options for patients with relapsed/refractory MM are discussed.

Adam C. Welch, PharmD, MBA, FAPhA, leads a panel discussion surrounding complications related to RSV infection.